SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened community interest driven by high short interest and rising borrow rates, fueling speculation about an impending short squeeze ahead of its upcoming earnings report. Investors are actively discussing the stock's potential for a significant breakout, emphasizing institutional acquisitions and the firm's role in the evolving enterprise AI market.

AIOS Tech, Inc. is an investment holding company, which engages in the provision of financing solutions to small- and mid-size enterprises. The company was founded on May 29, 2012 and is headquartered in Shanghai, China.

AIOS Tech Inc. - Ordinary Shares - Class A

AIOS Tech Inc.

AIOS Tech Inc. is generating significant community buzz due to its status as a low-float play and its history of volatile price swings following corporate actions like reverse splits. Traders are actively debating whether the stock represents a prime short-squeeze opportunity with potential for explosive gains or if it is a classic pump-and-dump scheme prone to rapid reversals and dilution risks.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is trending as investors react to a transformational 1.5 billion dollar acquisition of the Long Ridge Energy power plant, a strategic move aimed at pivoting the firm from a pure Bitcoin miner to a broader AI and HPC infrastructure provider. While the community is actively debating the company's management track record and the long-term impact of this capital-intensive expansion, the stock remains a focal point for high-beta traders monitoring the potential for a short squeeze alongside broader rotation into crypto-linked equities.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is facing significant downward pressure as investors react to a lowered full-year bookings forecast, with the company attributing the slowdown to disruptive new age-verification and child safety measures. The community is sharply divided, with bulls viewing the dip as a long-term accumulation opportunity despite the near-term friction, while bears focus on the potential for continued user growth headwinds and regulatory risks.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is surging on the back of institutional interest and speculative enthusiasm surrounding its electro-optic polymer technology, which is increasingly viewed as a critical component for high-speed AI infrastructure. The community is buzzing over potential foundry partnerships and the broader validation of the sector, with many investors holding for long-term catalysts while closely monitoring for any official updates on commercialization.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing intense volatility and institutional attention as investors debate its role in the AI datacenter 'supercycle' versus concerns over its current valuation and lack of profitability. The community remains sharply divided, with bulls pointing to expanding production capacity and high-speed transceiver demand while shorts anticipate a potential correction due to the stock's rapid appreciation and insider activity.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors digest news of potential FDA leadership changes, with the community closely tracking rumors of a former company VP being considered for a key regulatory role. The optimism is fueled by strong HOPE-3 Phase 3 clinical data for its lead therapy, leading many to believe that the path to approval is nearing completion despite recent price volatility caused by speculative short-selling.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is seeing a surge in investor optimism driven by positive registrations in key European markets and anticipation around upcoming AI and robotics product updates. The community remains deeply divided, with bulls actively buying calls to fuel a potential squeeze toward key technical levels while bears continue to highlight extreme valuation concerns and ongoing leadership volatility.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is currently generating significant investor interest due to strong revenue growth and expectations for its upcoming earnings report. The community is actively discussing the company's AI-driven marketing capabilities, while some express frustration over price volatility and perceived market manipulation.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending following the announcement of a massive $2.8 billion AI infrastructure expansion with Yotta Data Services, which has reignited intense community debate regarding the company's valuation, contract execution risk, and short-interest dynamics. While bullish investors point to the significant project pipeline and strategic partnerships as signs of a pending breakout, bears continue to express skepticism regarding the company's revenue recognition, lack of formal guidance, and history of unfulfilled promises.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The financing includes $5 million in upfront proceeds and $19 million tied to the exercise of warrants.</li><li>Funds will be used to support general operations, business development, and ongoing research and development, the company said.</li><li>Recently, Kiora’s trial to treat retinitis pigmentosa entered the patient dosing phase.</li></ul>Shares of Kiora Pharmaceuticals, Inc. (KPRX) jumped more than 17% in pre-market trading on Tuesday after the company unveiled a $24 million private placement deal, signaling fresh support for its ongoing eye disease treatment pipeline.If the premarket levels hold after the opening bell, <a href="https://stocktwits.com/symbol/KPRX">KPRX shares</a> would trade at their highest levels in more than two months.<h2 class="st-heading-2">KPRX To Receive $5 Million Upfront</h2>The financing includes $5 million in upfront proceeds, with an additional $19 million tied to the potential exercise of milestone-based warrants. The investment was led by Perceptive Advisors and ADAR1 Capital Management.The offering was priced at-the-market, with each share and prefunded warrant sold together at $2.543. These include short-term Tranche A-1 warrants and longer-term Tranche A-2 warrants, both exercisable at $1.94 per share. The Tranche A-2 warrants are valid for up to four years, but their term shortens to 30 days once any of Kiora completes enrolment in a Phase 3 trial.KPRX stock closed at $2.02 on Monday.Kiora said it plans to use the initial funds to support general operations, business development, and ongoing research and development.Recently, Kiora advanced its pipeline with KIO-301 entering patient dosing in the Phase 2 ABACUS-2 trial for retinitis pigmentosa, a rare disease that causes retinal degeneration.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘bullish’ a day earlier, amid ‘extremely high’ message volumes.Chatter was mixed, with one user calling the placement “solid news.”<stembedurl>https://stocktwits.com/The_Assassin/message/649554703</stembedurl>Another user expects the stock to fall below $1 by the end of the week.<stembedurl>https://stocktwits.com/Shortski/message/649556539</stembedurl>Year-to-date, the stock has climbed by around 2%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Last week, Baird maintained AYI’s ‘neutral’ rating but cut price target to $320 from $375. (Representative image: Getty Images)

Why Did KPRX Stock Surge 17% Pre-Market Today?

Kiora Pharmaceuticals (KPRX) - The company announced a $24 million private placement, led by Perceptive Advisors and ADAR1 Capital Management.

Equity

The company announced a $24 million private placement, led by Perceptive Advisors and ADAR1 Capital Management.

Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders

Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting...

Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know

Kiora Pharmaceuticals (KPRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.

Current Price	$2.46
Prev Close	$2.35
Open	$2.34
Dividend Yield	0.00%
50-Day Moving Average	$2.18
Beta	0.62
Avg. Volume	31,568.10
PE Ratio	-0.84

52-Week High	$4.18
52-Week Low	$1.76
Market Capitalization	$9.28M
EPS (Annual)	-$2.60
Price to Book	0.55
Revenue Per Employee	$0.00

KPRX
Kiora Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KPRX News

KPRXKiora Pharmaceuticals Inc